P. Selnes

发表

Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial temporal lobe atrophy in subjective cognitive impairment and mild cognitive impairment.

P. Selnes, D. Aarsland, A. Bjørnerud, 2013, Journal of Alzheimer's disease : JAD.

Impaired synaptic function is linked to cognition in Parkinson's disease

K. Blennow, P. Selnes, D. Aarsland, 2017, Annals of clinical and translational neurology.

Convergent Results from Neuropsychology and from Neuroimaging in Patients with Mild Cognitive Impairment

P. Selnes, E. Hessen, I. Reinvang, 2017, Dementia and Geriatric Cognitive Disorders.

Hippocampal Subfield Atrophy in Multi-Domain but Not Amnestic Mild Cognitive Impairment

P. Selnes, E. Hessen, I. Reinvang, 2015, Dementia and Geriatric Cognitive Disorders.

Mild cognitive impairment: cerebrospinal fluid tau biomarker pathologic levels and longitudinal changes in white matter integrity.

P. Selnes, A. Bjørnerud, L. Gjerstad, 2013, Radiology.

Executive dysfunction in mild cognitive impairment is associated with changes in frontal and cingulate white matter tracts.

P. Selnes, D. Aarsland, L. Gjerstad, 2011, Journal of Alzheimer's disease : JAD.

Pre-dementia Memory Impairment is Associated with White Matter Tract Affection

P. Selnes, I. Reinvang, R. Grambaite, 2010, Journal of the International Neuropsychological Society.

Hippocampal Complex Atrophy in Poststroke and Mild Cognitive Impairment

P. Selnes, A. Bjørnerud, L. Gjerstad, 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Hippocampal subfield atrophy in relation to cerebrospinal fluid biomarkers and cognition in early Parkinson’s disease: a cross-sectional study

P. Selnes, D. Aarsland, A. Bjørnerud, 2016, npj Parkinson's Disease.

Amyloid Dysmetabolism Relates to Reduced Glucose Uptake in White Matter Hyperintensities

P. Selnes, A. Bjørnerud, T. Fladby, 2016, Front. Neurol..

Correction of partial volume effect in 18F-FDG PET brain studies using coregistered MR volumes: Voxel based analysis of tracer uptake in the white matter

Christopher Coello, Frode Willoch, Per Selnes, 2013, NeuroImage.

[18F]-Flutemetamol Uptake in Cortex and White Matter: Comparison with Cerebrospinal Fluid Biomarkers and [18F]-Fludeoxyglucose

P. Selnes, A. Bjørnerud, T. Fladby, 2018, Journal of Alzheimer's disease : JAD.

Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer’s Disease

P. Selnes, A. Bjørnerud, R. Grambaite, 2017, Front. Aging Neurosci..

Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid

Per Selnes, Tormod Fladby, Henrik Zetterberg, 2010, Cerebrospinal Fluid Research.

Diffusion tensor and restriction spectrum imaging reflect different aspects of neurodegeneration in Parkinson’s disease

P. Selnes, A. Bjørnerud, T. Fladby, 2019, PloS one.

No evidence for amyloid pathology as a key mediator of neurodegeneration post-stroke - a seven-year follow-up study

S. Pendlebury, P. Selnes, M. Beyer, 2020, BMC Neurology.

Automatic WML segmentation and quantification using a machine learning approach

P. Selnes, A. Bjørnerud, T. Fladby, 2010 .

Phenotype‐informed polygenic risk scores are associated with worse outcome in individuals at risk of Alzheimer's disease

O. Andreassen, F. Bettella, P. Selnes, 2022, Alzheimer's & dementia.

Segmenting white matter hyperintensities on isotropic three-dimensional Fluid Attenuated Inversion Recovery magnetic resonance images: A comparison of Deep learning tools on a Norwegian national imaging database

P. Selnes, A. Bjørnerud, T. Fladby, 2022, SSRN Electronic Journal.

INVESTIGATING ARTERIAL SPIN LABELING AS A LARGE VESSEL CORRELATE OF SVD, AD, AND PD

F. Barkhof, P. Selnes, A. Bjørnerud, 2018, Alzheimer's & Dementia.

Stable cerebrospinal fluid neurogranin and β-site amyloid precursor protein cleaving enzyme 1 levels differentiate predementia Alzheimer’s disease patients

K. Blennow, B. Winblad, P. Visser, 2022, Brain communications.

White matter integrity and cognition in Parkinson's disease: a cross-sectional study

P. Selnes, D. Aarsland, A. Bjørnerud, 2014, BMJ Open.

P. Selnes, A. Bjørnerud, T. Fladby, 2022, SSRN Electronic Journal.

Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline

P. Selnes, E. Hessen, I. Reinvang, 2017, Brain and behavior.

Improved Automatic Segmentation of White Matter Hyperintensities in MRI Based on Multilevel Lesion Features

Estela Díaz-López, Atle Bjørnerud, Tormod Fladby, 2017, Neuroinformatics.

Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

W. M. van der Flier, D. Rujescu, I. Giegling, 2022, Acta Neuropathologica.

A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease

Laurent F. Thomas, A. Auton, H. Stefánsson, 2021, Nature Genetics.

Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns

P. Selnes, D. Aarsland, A. Bjørnerud, 2020, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Detecting At-Risk Alzheimer’s Disease Cases

P. Selnes, D. Aarsland, E. Hessen, 2017, Journal of Alzheimer's disease : JAD.

White matter imaging changes in subjective and mild cognitive impairment

Anders M. Fjell, Atle Bjørnerud, Per Selnes, 2012, Alzheimer's & Dementia.

Altered DNA base excision repair profile in brain tissue and blood in Alzheimer’s disease

P. Selnes, V. Stenset, T. Fladby, 2016, Molecular Brain.

Neurobiological correlates of depressive symptoms in people with subjective and mild cognitive impairment

P. Selnes, D. Aarsland, A. Bjørnerud, 2015, Acta psychiatrica Scandinavica.

Correlates of Subjective and Mild Cognitive Impairment: Depressive Symptoms and CSF Biomarkers

P. Selnes, D. Aarsland, E. Hessen, 2013, Dementia and Geriatric Cognitive Disorders Extra.

Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.

Keith A. Johnson, D. Y. Lee, W. M. van der Flier, 2022, JAMA neurology.

Glial activation and inflammation along the Alzheimer’s disease continuum

P. Selnes, D. Aarsland, T. Fladby, 2019, Journal of Neuroinflammation.

Cerebrospinal fluid neurogranin/β-site APP-cleaving enzyme 1 predicts cognitive decline in preclinical Alzheimer's disease

P. Selnes, D. Aarsland, E. Hessen, 2018, Alzheimer's & dementia.

Amyloid Plaques and Symptoms of Depression Links to Medical Help-Seeking due to Subjective Cognitive Decline

P. Selnes, E. Hessen, T. Fladby, 2020, Journal of Alzheimer's disease : JAD.

Neuropsychological Profiles in Mild Cognitive Impairment due to Alzheimer’s and Parkinson’s Diseases

P. Selnes, D. Aarsland, E. Hessen, 2016, Journal of Parkinson's disease.

White matter hyperintensity microstructure in amyloid dysmetabolism

P. Selnes, A. Bjørnerud, T. Fladby, 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Glial activation and inflammation along the Alzheimer’s disease continuum

P. Selnes, D. Aarsland, T. Fladby, 2019, Journal of Neuroinflammation.

P. Selnes, A. Wallin, E. Olsson, 2018, Alzheimer's & dementia.

The ANeED study: Ambroxol in new and early dementia with Lewy bodies

P. Selnes, A. Rongve, C. Tzoulis, 2020, Alzheimer's & Dementia.

Altered DNA base excision repair profile in brain tissue and blood in Alzheimer’s disease

P. Selnes, V. Stenset, T. Fladby, 2016, Molecular Brain.

Mitochondrial transcription factor A (TFAM) rs1937 and AP endonuclease 1 (APE1) rs1130409 alleles are associated with reduced cognitive performance

P. Selnes, I. Reinvang, V. Stenset, 2017, Neuroscience Letters.

Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort.

Turi O. Dalaker, P. Selnes, A. Bjørnerud, 2023, Journal of Alzheimer's disease : JAD.

Association between total-Tau and brain atrophy one year after first-ever stroke